Alto Neuroscience to Participate in Upcoming Investor Conferences

Oct 28, 2025 7:34 AM Eastern Daylight Time Alto Neuroscience to Participate in Upcoming Investor Conferences Share MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Alto Neuroscience, Inc. ("Alto†) (NYSE: ANRO) a clinical-stage biopharmaceutical company focused on the development of novel precision medicines for neuropsychiatric disorders, today announced that members of the Company's management team will present at the following upcoming investor conferences: Available presentations will be accessible via a live w ...